“…Conventional virus isolation from urine or saliva is still considered the ''gold standard'' for identification of newborns with congenital CMV infection, but the method is laborious, not amenable to automation and thus unsuitable for large-scale screening [Schleiss, 2008;Syggelou et al, 2010]. Molecular methods, such as the polymerase chain reaction (PCR), are considered currently to be the most appropriate methods for CMV screening of the newborn [Schlesinger et al, 2003;Paixã o et al, 2005;Barbi et al, 2006;Boppana et al, 2010]. However, due to the diverse results obtained in recent major screening studies, the question of which clinical sample saliva, urine or dried blood spots (DBS), is best suited for large-scale neonatal CMV screening is still matter of intense debate [Dollard and Schleiss, 2010;Kharrazi et al, 2010;de Vries et al, 2010;Boppana et al, 2011;Cannon et al, 2011;Leruez-Ville et al, 2011].…”